Dose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all?
a Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn and German CLL Study Group, University of Cologne , Cologne , Germany ;
Paula
P
Cramer
a Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn and German CLL Study Group, University of Cologne , Cologne , Germany ;
Petra
P
Langerbeins
a Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn and German CLL Study Group, University of Cologne , Cologne , Germany ;
Kirsten
K
Fischer
a Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn and German CLL Study Group, University of Cologne , Cologne , Germany ;
Barbara
B
Eichhorst
a Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn and German CLL Study Group, University of Cologne , Cologne , Germany ;|b CECAD - Cologne Cluster of Excellence in Cellular Stress Responses in Aging-associated Diseases , Cologne , Germany ;
Michael
M
Hallek
a Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn and German CLL Study Group, University of Cologne , Cologne , Germany ;|c Department of Geriatric Medicine , St. Marien Hospital , Cologne , Germany.
Valentin
V
Goede
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D003520:Cyclophosphamide